References
- O’Gara, Patrick T., et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61(4):e78–e140.
- Claessen, Bimmer E., et al. Stent thrombosis: a clinical perspective. JACC: Cardiovasc Interventions 2014; 7(10):1081–1092.
- Cutlip, Donald E., et al. Clinical end points in coronary stent trials a case for standardized definitions. Circulation 2007; 115(17):2344–2351.
- Chechi T, Vecchio S, Vittori G, et al. ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients. J Am Coll Cardiol 2008;51:2396.
- van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009;53:1399.
- Holmes DR Jr, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol 2010;56:1357.
- Croce K. Antiplatelet Therapy After Percutaneous Coronary Intervention: Should Another Regimen Be “TAPT”? Circ Cardiovasc Interv 2010;3:3–5.
- Esposito G. Responsiveness to P2Y12 receptor inhibitors. Curr Opin Cardiol 2011;26(suppl 1):S31–S37.
- Piccolo R, Di Gioia G, Niglio T, et al. Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome. Angiology 2014;65(2):130–136.
- Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndrome. N Engl J Med 2009;361(11):1045–1057.
- Nawarskas J, Snowden S. Critical appraisal of ticagrelor in the management of acute coronary syndrome. Therap Clini Risk Manag 2011;7:473–488.
- Bagai A, et al. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention insights into contemporary practice from the national cardiovascular data registry. Circulation: Cardiovasc Interventions 2014;7(4):585–593.
- Husted S, Van Giezen J. J. J. Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovasc Ther 2009;27(4):259–274.
- Gurbel PA, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease the ONSET/OFFSET study. Circulation 2009;120(25):2577–2585.
- Bagai A, et al. Pharmacodynamic and Clinical Implications of Switching Between P2Y12 Receptor Antagonists: Considerations for Practice. Crit Pathways Cardiol 2014;13(4):156–158.
- Faxon DP. How to manage antiplatelet therapy for stenting in a patient requiring oral anticoagulants. Curr Treat Options Cardiovasc Med 2013;15(1):11–20.
- Rollini F, Franchi F, Angiolillo DJ. Switching P2Y12-receptor inhibitors in patients with coronary artery disease. Nat Rev Cardiol 2016;13:11–27.
- Sabatine MS, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 2005;294(10):1224–1232.
- Patti G, et al. Outcome comparison of 600-and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study. J Am Coll Cardiol 2011;58(15):1592–1599.
- De Luca L, et al. Switching of platelet P2Y 12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations. Am Heart J 2016;176:44–52.
- Pourdjabbar A, et al. Optimizing crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome: The Capital Opti-Cross Randomized Trial. JACC 2015;65(10_S).
- Angiolillo DJ, et al. Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease (SWAP-4). Sponsor: University of Florida. Clin Gov Identifier: NCT02287909.
- Alexopoulos D, et al. In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome. Am Heart J 2014;167(1):68–76.
- Bagai A, et al. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the TRANSLATE-ACS study. Eur Heart J: Acute Cardiovasc Care 2015;4(6):499–508.